A
new study supports consuming eggs in moderation after finding no evidence that
eggs increase the risk of cardiovascular disease.
Conditions
that affect the heart or blood vessels are collectively known as cardiovascular
diseases. These include atherosclerosis (hardening of the arteries), coronary
artery disease, heart valve disease, arrhythmia (irregular heartbeat), heart
failure, high blood pressure, low blood pressure, shock, endocarditis
(bacterial infection of the heart), diseases of the aorta and its branches,
disorders of the peripheral vascular system and congenital heart disease.
Reducing
dietary cholesterol is important for preventing cardiovascular disease (CVD).
Researchers from Harvard Medical School explained that although eggs are high
in cholesterol, there is limited and inconsistent evidence that egg consumption
increases CVD risk and mortality.
The
researchers examined the association between egg consumption and cardiovascular
disease in 21,327 participants from the Physicians' Health Study I. Egg
consumption was assessed with an abbreviated food questionnaire.
After
an average follow-up of 20 years, 1,550 new heart attacks, 1,342 incident
strokes and 5,169 deaths occurred. The study found that egg consumption was not
associated with incident heart attack or stroke.
The
study authors concluded that occasional egg consumption does not seem to
influence the risk of CVD in males. However, egg consumption was positively
correlated with mortality, especially in diabetic subjects.
Integrative
therapies with strong scientific evidence in the treatment of heart conditions
include beta-glucan, beta-sitosterol, niacin, omega-3 fatty acids, policosanol,
psyllium, red yeast rice and soy. These can be ingested through a healthy diet
in addition to eggs.
Beta-glucan
is a fiber that comes from the cell walls of algae, bacteria, fungi, yeasts and
plants. Numerous trials have examined the effects of oral beta-glucan on
cholesterol. Small reductions in total and low density lipoprotein (LDL) cholesterol
("bad" cholesterol) have been reported. Little to no significant
changes have been noted to occur on triglyceride levels or high density
lipoprotein (HDL) cholesterol ("good" cholesterol) levels.
Beta-sitosterol
is found in plant-based foods such as fruits, vegetables, soybeans, breads,
peanuts and peanut products. It is also found in bourbon and oils. Many human
and animal studies have found that supplementation of beta-sitosterol into the
diet decreases total serum cholesterol as well as low-density lipoprotein
cholesterol.
Niacin,
also known as vitamin B3 or nicotinic acid, is a well-accepted treatment for
high cholesterol. Multiple studies show that niacin (not niacinamide) has
significant benefits on levels of high-density cholesterol. Niacin has been
shown to produce better results than prescription drugs. There are also
benefits on levels of low-density cholesterol, although these effects are less
dramatic.
Omega-3
fatty acids are found in fish oil and certain plant/nut oils. Fish oil contains
both docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA). Multiple human
trials report small reductions in blood pressure with intake of omega-3 fatty
acids. There is strong scientific evidence from human trials that omega-3 fatty
acids from fish or fish oil supplements (EPA + DHA) significantly reduce blood
triglyceride levels. Benefits appear to be dose-dependent. Fish oil supplements
also appear to cause small improvements (increases) in high-density
lipoprotein. However, increases (worsening) in low-density lipoprotein levels
are also observed. The American Heart Association has published recommendations
for EPA + DHA. Because of the risk of bleeding from omega-3 fatty acids, a
qualified healthcare provider should be consulted prior to starting treatment
with supplements.
Policosanol
is a natural mixture of alcohols derived from plant-based waxes that has been
shown to lower cholesterol. Policosanol has been used and recommended to treat
high cholesterol (hypercholesterolemia). Numerous studies have analyzed the
effects of policosanol on cholesterol levels and have found benefits. At this
time, the evidence supporting the efficacy of this agent is compelling,
although greater acceptance in the U.S. market may await additional larger
studies.
Psyllium,
also known as ispaghula, comes from the husks of the seeds of Plantago ovata.
Psyllium is well studied as a lipid-lowering agent with generally modest
reductions seen in blood levels of total cholesterol and low-density
lipoprotein. Because only small reductions have been observed, people with high
cholesterol should discuss the use of more potent agents with their healthcare
providers. Effects have been observed in adults and children, although
long-term safety in children is not established.
Red
yeast rice (RYR) is the product of yeast (Monascus purpureus) grown on
rice. Since the 1970s, human studies have reported that red yeast lowers blood
levels of total cholesterol, low-density lipoprotein/LDL and triglyceride
levels. Other products containing red yeast rice extract can still be
purchased. However, these products may not be standardized and effects are
unpredictable. For lowering cholesterol, there is better evidence for using
prescription drugs such as lovastatin.
Soy
is a subtropical plant native to southeastern Asia. Numerous human studies
report that adding soy protein to the diet can moderately decrease blood levels
of total cholesterol and low-density lipoprotein. Small reductions in
triglycerides may also occur, while high-density lipoprotein does not seem to
be significantly altered. It is unknown if products containing isolated soy
isoflavones have the same effects as regular dietary intake of soy protein.
For
more information on these therapies, please visit Natural Standard's Foods, Herbs & Supplements and Medical
Conditions databases.